Suppr超能文献

补充和替代医学治疗多发性硬化症。

Complementary and alternative medicine for the treatment of multiple sclerosis.

机构信息

Department of Neurology L226, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA.

出版信息

Expert Rev Clin Immunol. 2010 May;6(3):381-95. doi: 10.1586/eci.10.12.

Abstract

Multiple sclerosis (MS) is a chronic disabling disease of the CNS that affects people during early adulthood. Despite several US FDA-approved medications, the treatment options in MS are limited. Many people with MS explore complementary and alternative medicine (CAM) treatments to help control their MS and treat their symptoms. Surveys suggest that up to 70% of people with MS have tried one or more CAM treatment for their MS. People with MS using CAM generally report deriving some benefit from the therapies. The CAM therapies most frequently used include diet, omega-3 fatty acids and antioxidants. There is very limited research evaluating the safety and effectiveness of CAM in MS. The most promising among CAM therapies that warrant further investigation are a low-fat diet, omega-3 fatty acids, lipoic acid and vitamin D supplementation as potential anti-inflammatory and neuroprotective agents in both relapsing and progressive forms of MS. There is very limited research evaluating the safety and effectiveness of CAM in MS. However, in recent years, the NIH and the National MS Society have been actively supporting the research in this very important area.

摘要

多发性硬化症(MS)是一种影响年轻人的中枢神经系统慢性致残疾病。尽管有几种美国食品和药物管理局批准的药物,但 MS 的治疗选择有限。许多 MS 患者探索补充和替代医学(CAM)治疗方法来帮助控制 MS 并治疗其症状。调查表明,高达 70%的 MS 患者曾尝试过一种或多种用于 MS 的 CAM 治疗方法。使用 CAM 的 MS 患者通常报告说从治疗中获得了一些益处。最常使用的 CAM 疗法包括饮食、欧米伽-3 脂肪酸和抗氧化剂。关于 CAM 在 MS 中的安全性和有效性的研究非常有限。CAM 疗法中最有前途的是低脂饮食、欧米伽-3 脂肪酸、硫辛酸和维生素 D 补充剂,它们可能是复发和进行性 MS 形式的潜在抗炎和神经保护剂。关于 CAM 在 MS 中的安全性和有效性的研究非常有限。然而,近年来,NIH 和国家多发性硬化症协会一直在积极支持这一非常重要领域的研究。

相似文献

1
Complementary and alternative medicine for the treatment of multiple sclerosis.
Expert Rev Clin Immunol. 2010 May;6(3):381-95. doi: 10.1586/eci.10.12.
3
Anti-inflammatory nutritional intervention in patients with relapsing-remitting and primary-progressive multiple sclerosis: A pilot study.
Exp Biol Med (Maywood). 2016 Mar;241(6):620-35. doi: 10.1177/1535370215618462. Epub 2016 Jan 18.
4
Complementary and alternative medicine: is there a role in multiple sclerosis?
Curr Neurol Neurosci Rep. 2006 May;6(3):259-67. doi: 10.1007/s11910-006-0014-y.
5
Dietary interventions for multiple sclerosis-related outcomes.
Cochrane Database Syst Rev. 2020 May 19;5(5):CD004192. doi: 10.1002/14651858.CD004192.pub4.
6
Dietary interventions for multiple sclerosis.
Cochrane Database Syst Rev. 2012 Dec 12;12:CD004192. doi: 10.1002/14651858.CD004192.pub3.
7
Complementary and alternative medicine in multiple sclerosis: a questionnaire-based study.
Neurol Neurochir Pol. 2022;56(5):428-434. doi: 10.5603/PJNNS.a2022.0059. Epub 2022 Sep 7.
8
Azathioprine for people with multiple sclerosis.
Cochrane Database Syst Rev. 2024 Dec 9;12(12):CD015005. doi: 10.1002/14651858.CD015005.pub2.
9
Use of complementary and alternative medicine in vitiligo: a cross-sectional survey.
Arch Dermatol Res. 2024 Apr 23;316(5):126. doi: 10.1007/s00403-024-02872-x.
10
Complementary and alternative medicine in multiple sclerosis: survey of licensed naturopaths.
J Altern Complement Med. 2004 Oct;10(5):891-7. doi: 10.1089/acm.2004.10.891.

引用本文的文献

4
Polypharmacy in Multiple Sclerosis: Prevalence, Risks, and Mitigation Strategies.
Curr Neurol Neurosci Rep. 2023 Sep;23(9):521-529. doi: 10.1007/s11910-023-01289-9. Epub 2023 Jul 31.
5
Medicinal herbs and multiple sclerosis: Overview on the hard balance between new therapeutic strategy and occupational health risk.
Front Cell Neurosci. 2022 Nov 10;16:985943. doi: 10.3389/fncel.2022.985943. eCollection 2022.
6
Mapping the Literature on Diet and Multiple Sclerosis: A Data-Driven Approach.
Nutrients. 2022 Nov 14;14(22):4820. doi: 10.3390/nu14224820.
8
Complementary and alternative therapies in multiple sclerosis: a systematic literature classification and analysis.
Acta Neurol Belg. 2022 Apr;122(2):281-303. doi: 10.1007/s13760-021-01847-3. Epub 2022 Jan 21.
9
Assessment of Multiple Sclerosis Awareness and Knowledge among the Community of Jeddah, Saudi Arabia.
J Neurosci Rural Pract. 2021 Sep 16;12(4):733-738. doi: 10.1055/s-0041-1734009. eCollection 2021 Oct.

本文引用的文献

5
Complementary and alternative medicines and dietary interventions in multiple sclerosis: what is being used in South Australia and why?
Complement Ther Med. 2009 Aug;17(4):216-23. doi: 10.1016/j.ctim.2009.03.001. Epub 2009 Apr 21.
7
Therapeutic potential of n-3 polyunsaturated fatty acids in disease.
Am J Health Syst Pharm. 2009 Jul 1;66(13):1169-79. doi: 10.2146/ajhp080411.
8
Phase I trial of daily oral Polyphenon E in patients with asymptomatic Rai stage 0 to II chronic lymphocytic leukemia.
J Clin Oncol. 2009 Aug 10;27(23):3808-14. doi: 10.1200/JCO.2008.21.1284. Epub 2009 May 26.
9
Vitamin D status and effect of low-dose cholecalciferol and high-dose ergocalciferol supplementation in multiple sclerosis.
Mult Scler. 2009 Jun;15(6):735-40. doi: 10.1177/1352458509102844. Epub 2009 Apr 21.
10
Immunomodulatory effects of Vitamin D in multiple sclerosis.
Brain. 2009 May;132(Pt 5):1146-60. doi: 10.1093/brain/awp033. Epub 2009 Mar 24.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验